How Immunotherapy Turned Deadly Melanoma Into a Treatable Cancer
A new review details how immune checkpoint inhibitors, cell therapies, vaccines and oncolytic viruses have transformed melanoma treatment while highlighting ...
A new review details how immune checkpoint inhibitors, cell therapies, vaccines and oncolytic viruses have transformed melanoma treatment while highlighting ...
A new review maps the recurrent mutations and signaling crosstalk driving gallbladder cancer, identifying ERBB2 and KRAS as hub targets ...
A new review in the Journal of Translational Medicine describes how brain tumor organoid platforms are being used to reconstruct ...
A new grading system for tertiary lymphoid structures in glioblastoma tissue identifies patients with significantly longer survival and may guide ...
A 40-year-old London patient with no occupational asbestos history was diagnosed with pleural mesothelioma, pointing researchers toward childhood environmental exposure ...
A nationwide survey of 120 senior Chinese specialists reveals that over half of newly diagnosed intermediate-stage liver cancer patients are ...
A new meta-analysis of five observational studies finds that adding pembrolizumab to neoadjuvant chemotherapy in early-stage triple-negative breast cancer appears ...
Researchers have built a 13-gene lysosome-related signature that predicts survival, immune landscape, and drug responses in lung adenocarcinoma patients.
A 25-year bibliometric analysis combining artificial intelligence with citation data shows cancer cachexia research is growing at 6.7 percent annually, ...
A Japanese case report describes more than three years of progression-free survival in pulmonary tumour thrombotic microangiopathy after prompt nivolumab ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine